BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 18058612)

  • 1. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
    Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
    Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Martínez-Rivera Mde L; Rodríguez-Tovar AV; Herrera-Alvarez S; Salas-Andonaegui ML; Nava-Xalpa MY; Méndez-Salas A; Tortoriello J
    Planta Med; 2009 Apr; 75(5):466-71. PubMed ID: 19189246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural changes on clinical isolates of Trichophyton rubrum, Trichophyton mentagrophytes, and Microsporum gypseum caused by Solanum chrysotrichum saponin SC-2.
    López-Villegas EO; Herrera-Arellano A; de Los Angeles Martínez-Rivera M; Alvarez L; Cano-Nepauseno M; Marquina S; Rodríguez-Tovar AV; Tortoriello J
    Planta Med; 2009 Nov; 75(14):1517-20. PubMed ID: 19551614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole.
    Herrera-Arellano A; Jiménez-Ferrer E; Vega-Pimentel AM; Martínez-Rivera Mde L; Hernández-Hernández M; Zamilpa A; Tortoriello J
    Planta Med; 2004 Jun; 70(6):483-8. PubMed ID: 15241887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences.
    Herrera-Arellano A; López-Villegas EO; Rodríguez-Tovar AV; Zamilpa A; Jiménez-Ferrer E; Tortoriello J; Martínez-Rivera MA
    Afr J Tradit Complement Altern Med; 2013; 10(3):410-7. PubMed ID: 24146467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of antifungal activity of Ononis spinosa L. ash used for the therapy of skin infections as folk remedies].
    Altuner EM; Ceter T; Işlek C
    Mikrobiyol Bul; 2010 Oct; 44(4):633-9. PubMed ID: 21063975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
    Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
    Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on Tinea pedis: a controlled and randomized clinical trial.
    Herrera-Arellano A; Rodríguez-Soberanes A; de los Angeles Martínez-Rivera M; Martínez-Cruz E; Zamilpa A; Alvarez L; Tortoriello J
    Planta Med; 2003 May; 69(5):390-5. PubMed ID: 12802717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal activity of phenylheptatriyne from Bidens cernua L. against yeasts.
    Rybalchenko NP; Prykhodko VA; Nagorna SS; Volynets NN; Ostapchuk AN; Klochko VV; Rybalchenko TV; Avdeeva LV
    Fitoterapia; 2010 Jul; 81(5):336-8. PubMed ID: 19837144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
    Tan GL; Peterson EM
    J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
    Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
    Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole.
    Mallié M; Montès B; Reynes J; Bastide JM
    Drugs Exp Clin Res; 1990; 16(10):509-13. PubMed ID: 2100733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of antifungal susceptibility testing of Candida species and trends of antifungal use in Niigata university medical and dental hospital].
    Aoki T; Moro H; Koshio N; Tamura T; Tanabe Y; Kawai H; Matsuto T; Okada M
    Rinsho Byori; 2010 Jul; 58(7):658-63. PubMed ID: 20715508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
    Seifert H; Aurbach U; Stefanik D; Cornely O
    Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent anti-microbial activity of traditional Chinese medicine herbs against Candida species.
    Seneviratne CJ; Wong RW; Samaranayake LP
    Mycoses; 2008 Jan; 51(1):30-4. PubMed ID: 18076592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of black tea polyphenols (catechins and theaflavins) against Candida species.
    Sitheeque MA; Panagoda GJ; Yau J; Amarakoon AM; Udagama UR; Samaranayake LP
    Chemotherapy; 2009; 55(3):189-96. PubMed ID: 19420933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of steroidal glycosides from Yucca gloriosa L.
    Favel A; Kemertelidze E; Benidze M; Fallague K; Regli P
    Phytother Res; 2005 Feb; 19(2):158-61. PubMed ID: 15852482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.